Other
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ4 2025
Last reportedQ1 2026
How to read this metric
Higher unrealized losses often signal rising interest rates or credit deterioration in the investment portfolio.
Detailed definition
This metric tracks the total gross unrealized losses on debt securities classified as available-for-sale. It represents...
Peer comparison
Unrealized losses are a key focus for investors during periods of rising interest rates, as they impact the bank's book value.
Metric ID:
other_available_for_sale_debt_securities_accumulated_gro_6005e2Historical Data
1 periods
| Q1 '26 | |
|---|---|
| Value | $13.20M |
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's debt securities, available-for-sale, accumulated gross unrealized loss, before tax?
- Vertex Pharmaceuticals (VRTX) reported debt securities, available-for-sale, accumulated gross unrealized loss, before tax of $13.20M in Q1 2026.
- What does debt securities, available-for-sale, accumulated gross unrealized loss, before tax mean?
- The total amount of unrealized losses on debt securities that are held for potential sale.